Pages that link to "Q39831180"
Jump to navigation
Jump to search
The following pages link to Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats (Q39831180):
Displaying 50 items.
- Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus (Q24293487) (← links)
- Investigational drugs to treat methicillin-resistant Staphylococcus aureus (Q26780246) (← links)
- Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients (Q33716613) (← links)
- Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model (Q33767412) (← links)
- Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections (Q33774261) (← links)
- Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence (Q33788238) (← links)
- Serodiversity of opsonic antibodies against Enterococcus faecalis--glycans of the cell wall revisited (Q33855583) (← links)
- Novel targeted immunotherapy approaches for staphylococcal infection. (Q33910565) (← links)
- Antibodies to a surface-exposed, N-terminal domain of aggregation substance are not protective in the rabbit model of Enterococcus faecalis infective endocarditis (Q33941747) (← links)
- Genetic and serologic evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and other Staphylococcus spp. from Europe and the United States (Q33968870) (← links)
- Immune evasion by staphylococci (Q33991798) (← links)
- Vaccine potential of poly-1-6 beta-D-N-succinylglucosamine, an immunoprotective surface polysaccharide of Staphylococcus aureus and Staphylococcus epidermidis (Q34041918) (← links)
- Staphylococcus aureus AI-2 quorum sensing associates with the KdpDE two-component system to regulate capsular polysaccharide synthesis and virulence. (Q34045106) (← links)
- Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections (Q34112608) (← links)
- Regulation of Staphylococcus aureus capsular polysaccharide expression by agr and sarA. (Q34116833) (← links)
- Model systems: modeling human staphylococcal arthritis and sepsis in the mouse (Q34297800) (← links)
- Staphylococcus aureus gene expression in a rat model of infective endocarditis. (Q34491802) (← links)
- Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis (Q34581644) (← links)
- Antibodies to Staphylococcus aureus serotype 8 capsular polysaccharide react with and protect against serotype 5 and 8 isolates (Q34595644) (← links)
- Evaluation of the protective immunity of a novel subunit fusion vaccine in a murine model of systemic MRSA infection (Q35063930) (← links)
- Staphylococcus aureus capsular polysaccharides (Q35630504) (← links)
- Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis). (Q35662677) (← links)
- Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide (Q35710178) (← links)
- Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials (Q35710192) (← links)
- Rationale for the development of immunotherapy regimens against enterococcal infections. (Q35970293) (← links)
- Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A. (Q36213353) (← links)
- Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia (Q36313264) (← links)
- An antidote for Staphylococcus aureus pneumonia? (Q36502876) (← links)
- Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection. (Q36548288) (← links)
- Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections (Q36609408) (← links)
- MsaB activates capsule production at the transcription level in Staphylococcus aureus (Q36966028) (← links)
- Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice (Q36974423) (← links)
- Innate Immunity of Adipose Tissue in Rodent Models of Local and Systemic Staphylococcus aureus Infection. (Q37744101) (← links)
- Strategies for and advances in the development ofStaphylococcus aureusprophylactic vaccines (Q37878489) (← links)
- Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors (Q38038043) (← links)
- A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults. (Q38415816) (← links)
- Synthetic peptide immunogens elicit polyclonal and monoclonal antibodies specific for linear epitopes in the D motifs of Staphylococcus aureus fibronectin-binding protein, which are composed of amino acids that are essential for fibronectin binding. (Q39514417) (← links)
- Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis (Q39537000) (← links)
- Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase (Q39537626) (← links)
- Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines. (Q39573071) (← links)
- Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection (Q40245675) (← links)
- Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo (Q40416064) (← links)
- Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus (Q41871463) (← links)
- Induction of Staphylococcus aureus-specific IgA and agglutination potency in milk of cows by mucosal immunization (Q47954890) (← links)
- Development of Antistaphylococcal Vaccines. (Q53987134) (← links)
- Models matter: the search for an effective Staphylococcus aureus vaccine (Q59806683) (← links)
- Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States (Q61818333) (← links)
- Immunization for Prevention of Infective Endocarditis (Q73235142) (← links)
- Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat (Q73870954) (← links)
- Staphylococcus aureus capsular polysaccharide type 5 conjugate and whole cell vaccines stimulate antibody responses in cattle (Q74100868) (← links)